# Sichuan Haisco Pharmaceutical Group trials: 30 (2026)

ClinicalTrials.gov lists 30 trials with Sichuan Haisco Pharmaceutical Group Co., Ltd as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Sichuan Haisco Pharmaceutical Group Co., Ltd: 30 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sichuan-haisco-pharmaceutical-group-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2020 | NCT04595916 | Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 4 | Completed | Acute Drug Induced Liver Injury | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04595916) |
| September 25, 2020 | NCT04564872 | HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 3 | Completed | Diabetes Mellitus, Type 2 | 465 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04564872) |
| September 21, 2020 | NCT04556851 | HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 3 | Completed | Diabetes Mellitus, Type 2 | 476 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04556851) |
| September 21, 2020 | NCT04556110 | A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04556110) |
| September 21, 2020 | NCT04556058 | A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04556058) |
| September 7, 2020 | NCT04540016 | Mass Balance and Biotransformation of \[14C\]HSK7653 in Human | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Type II Diabetes | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04540016) |
| August 25, 2020 | NCT04526496 | Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Healthy | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04526496) |
| December 30, 2019 | NCT04213196 | Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Healthy Volunteers | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04213196) |
| December 13, 2019 | NCT04197661 | Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly Subjects | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Healthy Elderly Subjects | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04197661) |
| November 1, 2019 | NCT04147416 | A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 2 | Completed | Sedation | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04147416) |
| October 30, 2019 | NCT04145596 | Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Hepatic Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04145596) |
| October 30, 2019 | NCT04145583 | A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04145583) |
| October 29, 2019 | NCT04142970 | Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Chronic Renal Impairment | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04142970) |
| October 1, 2019 | NCT04111159 | A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 3 | Completed | Sedation or Anesthesia | 267 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04111159) |
| October 1, 2019 | NCT04110886 | Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy Volunteers | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Postoperative Pain, Chronic Pain | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04110886) |
| August 13, 2019 | NCT04054063 | A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male... | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | General Anesthetic, Sedation | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04054063) |
| August 7, 2019 | NCT04048811 | A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery Patients | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 2 | Completed | Induction and Maintenance of General Anesthesia | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04048811) |
| July 30, 2019 | NCT04037657 | Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects. | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04037657) |
| July 26, 2019 | NCT04033939 | A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects. | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04033939) |
| July 23, 2019 | NCT04029766 | A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute... | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04029766) |
| January 18, 2019 | NCT03808844 | A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery... | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 3 | Completed | Induction of Anesthesia | 178 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03808844) |
| December 12, 2018 | NCT03773835 | A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy... | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03773835) |
| December 12, 2018 | NCT03773042 | A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 2 | Completed | Colonoscopy | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03773042) |
| November 29, 2018 | NCT03758469 | A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Completed | Anesthesia, Sedation | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03758469) |
| November 23, 2018 | NCT03751969 | A Study Evaluating the Mass Balance of Micro-dose\[14C\]HSK3486 Emulsion Injection in Healthy Adults | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 | Withdrawn | Anesthesia, Sedation | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03751969) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 19 |
| Phase 2 | 5 |
| Phase 3 | 5 |
| Phase 4 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 29 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 3 |
| Fasting | 1 |
| Chemical and Drug Induced Liver Injury | 1 |
| Pain, Postoperative | 1 |
| Chronic Pain | 1 |
| Pain | 1 |
| Renal Insufficiency, Chronic | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Beach resorts in the United States](https://specstream.ai/data/businesses/beach-resorts/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Occupational medicine clinics in the United States](https://specstream.ai/data/businesses/occupational-medicine-clinics/united-states)
- [Furniture rental companies in the United States](https://specstream.ai/data/businesses/furniture-rental-companies/united-states)
- [Business office supplies and stationery companies in the United States](https://specstream.ai/data/businesses/business-office-supplies-and-stationery-companies/united-states)
